Fluvir powder 3.93 g sachet 10 pcs.

Fluvir is a complex probiotic that contains 15 billion CFU of viable lacto- and bifidobacteria: Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis BS01 and fructooligosaccharides.

Fluvir for children is a complex probiotic containing 7.5 billion CFU of viable lacto- and bifidobacteria: Lactobacillus plantarum LP01 andLP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis BS01 and fructooligosaccharides.

Lactobacillus plantarum LP01 and LP02 and Lactobacillus rhamnosus LR04 and LR05 help to break down carbohydrates in the intestinal lumen with the formation of lactic acid. The acidic environment thus created has a positive effect on the development of the body’s own bifidobacteria, which constitute 85-95% of the intestinal microflora of adults and children. Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis:

1) show immunomodulatory properties: enhance specific IgA response and reduce the production of cytokines associated with inflammation; synthesize amino acids, pantothenic acid, vitamin K and B vitamins; promote absorption of iron, calcium, vitamin D;

2) show symbiosis, compensating each other’s metabolism and stimulate mutual growth; exhibit high antagonistic activity against a wide range of pathogenic and opportunistic microorganisms, inhibit the activity of staphylococci, shigellae, rotaviruses, Proteus, enteropathogenic E. coli and some yeast-like fungi, preventing their adhesion to the intestinal mucosa;

3) create favorable conditions for the development of beneficial intestinal microflora, maintain and regulate the physiological balance of the intestinal microflora, promote normalization of the gastrointestinal microbiocenosis.

Fructooligosaccharides are nutrient substrates for intestinal microflora and contribute to its active development, thus preventing dysbiosis and antibiotic-associated diarrhea.
It is not a medicine.

Pharmacological effect

Fluvir is a complex probiotic that contains 15 billion CFU of viable lacto- and bifidobacteria: Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis BS01 and fructooligosaccharides.

Fluvir for children is a complex probiotic that contains 7.5 billion CFU of viable lacto- and bifidobacteria: Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis BS01 and fructo-oligosaccharides.

Lactobacilli Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05 promote the breakdown of carbohydrates in the intestinal lumen with the formation of lactic acid. The acidic environment created in this way has a positive effect on the development of the body’s own bifidobacteria, which make up 85–95% of the intestinal microflora of adults and children. Lactobacilli Lactobacillus plantarum LP01 and LP02, Lactobacillus rhamnosus LR04 and LR05, Bifidobacterium lactis:

1) exhibit immunomodulatory properties: enhance the specific IgA response and reduce the production of cytokines associated with inflammation; synthesize amino acids, pantothenic acid, vitamin K and B vitamins; promote the absorption of iron, calcium, vitamin D;

2) exhibit symbiosis, compensating each other’s metabolism and stimulating mutual growth; exhibit high antagonistic activity against a wide range of pathogenic and conditionally pathogenic microorganisms, inhibit the vital activity of staphylococci, shigella, rotaviruses, Proteus, enteropathogenic Escherichia coli, some yeast-like fungi, preventing their adhesion to the intestinal mucosa;

3) create favorable conditions for the development of beneficial intestinal microflora, maintain and regulate the physiological balance of intestinal microflora, and contribute to the normalization of gastrointestinal microbiocenosis.

Fructooligosaccharides are a nutritious substrate for beneficial intestinal microflora and contribute to its active development, which prevents dysbiosis and antibiotic-associated diarrhea.
Not a medicine.

Special instructions

For maximum effectiveness, the interval between taking the dietary supplement and antibiotics should be 3 hours.

Composition

1 sachet contains:

2.5 billion viable bacteria Lactobacillus plantarum LP01,

2.5 billion viable bacteria Lactobacillus plantarum LP02,

2.5 billion viable bacteria Lactobacillus rhamnosus LR04,

2.5 billion viable bacteria Lactobacillus rhamnosus LR05;

5 billion viable bacteria Bifidobacterium lactis BS01;

excipients:

fructooligosaccharides,

potato maltodextrin,

insoluble fiber,

silica.

Contraindications

hypersensitivity to product components.

Short product description

Dietary supplement Not a medicine.
Before use, it is recommended to consult a doctor (specialist).

Manufacturer

Probiotic S.p.A., Switzerland